Pivotal role of CD103 in the development of psoriasiform dermatitis
Pivotal role of CD103 in the development of psoriasiform dermatitis
复制标题
DOI:
10.1038/s41598-020-65355-9
复制
发表时间:
2020-05-20
影响因子:
4.6
通讯作者:
Sato, Katsuaki
中科院分区:
文献类型:
--
作者:
Fukui, Takehito;Fukaya, Tomohiro;Sato, Katsuaki
The integrin alpha E known as CD103 binds integrin beta 7 to form the complete heterodimeric integrin molecule alpha E beta 7. CD103 is mainly expressed by lymphocytes within epithelial tissues of intestine, lung, and skin as well as subsets of mucosal and dermal conventional dendritic cells (cDCs). CD103 has been originally implicated in the attachment of lymphocytes to epithelium in the gut and skin through the interaction with E-cadherin expressed on intestinal epithelial cells, keratinocytes, and Langerhans cells (LCs). However, an impact of CD103 on the cutaneous immune responses and the development of inflammatory skin diseases remains elusive. Here, we report that CD103 regulates the development of psoriasiform dermatitis through the control of the function of cDCs. Deficiency in CD103 exacerbates psoriasiform dermatitis, accompanied by excessive epidermal hyperplasia and infiltration of inflammatory leukocytes. Furthermore, deficiency in CD103 not only accelerates the production of proinflammatory cytokines in psoriatic lesions but also promotes the generation of lymphocytes producing interleukin (IL)-17 in the skin-draining peripheral lymph nodes (PLNs). Under the deficiency in CD103, cDCs localized in PLNs enhance cytokine production following activation. Thus, our findings reveal a pivotal role for CD103 in the control of the function of cDCs to regulate cutaneous inflammation in psoriasiform dermatitis.